Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorpropamide-induced hyponatraemia.

H J Peak, A Horniblow

    The Medical Journal of Australia
    |December 6, 1975
    PubMed
    Summary
    This summary is machine-generated.

    This case report details a 69-year-old diabetic woman who developed hyponatraemia. The condition, linked to chlorpropamide use, resolved upon medication withdrawal, suggesting chlorpropamide as the causative agent.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of lignocaine and hydrocortisone in the diagnosis and management of chest wall pain masquerading as ischaemic cardiac pain.

    The Medical journal of Australia·1983
    Same author

    The clinical profile of hypertrophic cardiomyopathy.

    The Medical journal of Australia·1977
    Same author

    Pericarditis during infection with Mycoplasma pneumoniae.

    The Medical journal of Australia·1976
    Same author

    Uptake and release of immunoreactive insulin in coronary circulation in man: studies at rest, during exercise, and during glucose and insulin infusions.

    Recent advances in studies on cardiac structure and metabolism·1976
    Same author

    Letter: Lignocaine usage in evaluating chest pain.

    The Medical journal of Australia·1975
    Same author

    Rheumatic heart disease, 1970. A brief review for the general practitioner.

    The Medical journal of Australia·1971
    Same journal

    Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

    The Medical journal of Australia·2026
    Same journal

    Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

    The Medical journal of Australia·2026
    Same journal

    Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

    The Medical journal of Australia·2026
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Internal Medicine

    Background:

    • Diabetes mellitus is a common endocrine disorder.
    • Hyponatraemia, or low blood sodium, can have various causes.
    • Chlorpropamide is an oral hypoglycemic agent used to manage type 2 diabetes.

    Observation:

    • A 69-year-old female patient with diabetes presented with hyponatraemia.
    • The patient was being treated with chlorpropamide.
    • Symptoms of hyponatraemia worsened with increased chlorpropamide dosage.

    Findings:

    • A direct correlation was observed between chlorpropamide dosage and the severity of hyponatraemia.
    • Discontinuation of chlorpropamide led to the correction of hyponatraemia.
    • No other apparent causes for the hyponatraemia were identified.

    Related Experiment Videos

    Implications:

    • Chlorpropamide can be a potential cause of drug-induced hyponatraemia in diabetic patients.
    • Clinicians should consider chlorpropamide-induced hyponatraemia in diabetic patients presenting with low serum sodium.
    • Careful monitoring of electrolytes is recommended for patients on chlorpropamide therapy.